Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Loda

Showing results (371-380 of 409) with videos related to

Pageof 41
Sort By:
Blood|June 30, 2020
Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndromeElizabeth A Middleton, Xue-Yan He, Frederik Denorme, et al.
Nature|November 26, 2025
NSD2 targeting reverses plasticity and drug resistance in prostate cancerJia J Li, Alessandro Vasciaveo, Dimitris Karagiannis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2022
Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984Joseph W Kim, Rana R McKay, Marc R Radke, et al.
Nature|July 1, 2026
Retraction Note: NSD2 targeting reverses plasticity and drug resistance in prostate cancerJia J Li, Alessandro Vasciaveo, Dimitris Karagiannis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2015
A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate CancerNeeta Pandit-Taskar, Joseph A O'Donoghue, Jeremy C Durack, et al.
Nature|September 17, 2008
CDK8 is a colorectal cancer oncogene that regulates beta-catenin activityRon Firestein, Adam J Bass, So Young Kim, et al.
Nature|February 4, 2011
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progressionZhihu Ding, Chang-Jiun Wu, Gerald C Chu, et al.
Nature Communications|January 8, 2024
Distinct mesenchymal cell states mediate prostate cancer progressionHubert Pakula, Mohamed Omar, Ryan Carelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 2018
Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancerGiorgia Zadra, Caroline F Ribeiro, Paolo Chetta, et al.
Ebiomedicine|February 5, 2016
A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American menGyorgy Petrovics, Hua Li, Tanja Stümpel, et al.
Pageof 41

Showing results (371-380 of 409) with videos related to

Sort By:
Pageof 41
Blood|June 30, 2020
Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndromeElizabeth A Middleton, Xue-Yan He, Frederik Denorme, et al.
Nature|November 26, 2025
NSD2 targeting reverses plasticity and drug resistance in prostate cancerJia J Li, Alessandro Vasciaveo, Dimitris Karagiannis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2022
Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984Joseph W Kim, Rana R McKay, Marc R Radke, et al.
Nature|July 1, 2026
Retraction Note: NSD2 targeting reverses plasticity and drug resistance in prostate cancerJia J Li, Alessandro Vasciaveo, Dimitris Karagiannis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2015
A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate CancerNeeta Pandit-Taskar, Joseph A O'Donoghue, Jeremy C Durack, et al.
Nature|September 17, 2008
CDK8 is a colorectal cancer oncogene that regulates beta-catenin activityRon Firestein, Adam J Bass, So Young Kim, et al.
Nature|February 4, 2011
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progressionZhihu Ding, Chang-Jiun Wu, Gerald C Chu, et al.
Nature Communications|January 8, 2024
Distinct mesenchymal cell states mediate prostate cancer progressionHubert Pakula, Mohamed Omar, Ryan Carelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 2018
Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancerGiorgia Zadra, Caroline F Ribeiro, Paolo Chetta, et al.
Ebiomedicine|February 5, 2016
A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American menGyorgy Petrovics, Hua Li, Tanja Stümpel, et al.
Pageof 41